Genscript Biotech's H1 Loss Widens Genscript Biotech's (HKG:1548) attributable loss widened to $175.1 million in the first half from $93.6 million in the year-ago period, according to a Friday filing ...
Source LinkGenscript Biotech's H1 Loss Widens Genscript Biotech's (HKG:1548) attributable loss widened to $175.1 million in the first half from $93.6 million in the year-ago period, according to a Friday filing ...
Source Link
Comments